Epidemiology, incidence and mortality of Hodgkin’s cancer in the world and its relation with development
WCRJ 2018;
5 (2): e1085
DOI: 10.32113/wcrj_20186_1085
Topic: Epidemiology, Haematological oncology
Category: Original article
Abstract
Objective: There is a high incidence and mortality rate of Hodgkin’s cancer in all countries around the world. Due to the importance of knowledge about incidence and mortality rate of Hodgkin’s cancer, this study has been conducted to investigate the age-standardized incidence and mortality rate of this cancer, its relationship with the human development index (HDI) and its components in the world.
Materials and Methods: The study was conducted based on the world data of cancer and the World Bank (including the HDI and its components). Data about the age-specific incidence and mortality rate (ASR) for every country in 2012 were obtained from the global cancer project. To analyze data, correlation tests between incidence, death rates, HDI and its components were employed with a significance level of 0.05 using SPSS software.
Results: Globally in 2012, the standardized incidence and mortality rate of Hodgkin lymphoma were 0.9 and 0.3 per hundred thousand people, respectively. A positive statistically significant correlation was seen between Hodgkin’s lymphoma cancer’s standardized incidence rate and HDI (r: 0.626; p<0.001). A negative correlation was observed between the standardized mortality rate of Hodgkin lymphoma cancer and HDI, which was statistically significant (r: -0.181; p=0.019).
Conclusions: The age-standardized incidence rate of Hodgkin’s cancer is higher in countries with higher HDI. The age-standardized mortality rate is higher in countries with higher HDI than countries with lower HDI. Informing people about the risk factors of the disease and prevention is recommended for reducing the incidence of disease.
Materials and Methods: The study was conducted based on the world data of cancer and the World Bank (including the HDI and its components). Data about the age-specific incidence and mortality rate (ASR) for every country in 2012 were obtained from the global cancer project. To analyze data, correlation tests between incidence, death rates, HDI and its components were employed with a significance level of 0.05 using SPSS software.
Results: Globally in 2012, the standardized incidence and mortality rate of Hodgkin lymphoma were 0.9 and 0.3 per hundred thousand people, respectively. A positive statistically significant correlation was seen between Hodgkin’s lymphoma cancer’s standardized incidence rate and HDI (r: 0.626; p<0.001). A negative correlation was observed between the standardized mortality rate of Hodgkin lymphoma cancer and HDI, which was statistically significant (r: -0.181; p=0.019).
Conclusions: The age-standardized incidence rate of Hodgkin’s cancer is higher in countries with higher HDI. The age-standardized mortality rate is higher in countries with higher HDI than countries with lower HDI. Informing people about the risk factors of the disease and prevention is recommended for reducing the incidence of disease.
To cite this article
Epidemiology, incidence and mortality of Hodgkin’s cancer in the world and its relation with development
WCRJ 2018;
5 (2): e1085
DOI: 10.32113/wcrj_20186_1085
Publication History
Submission date: 12 Feb 2018
Revised on: 19 Feb 2018
Accepted on: 15 Mar 2018
Published online: 26 Jun 2018
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.